Skip directly to page options Skip directly to A-Z link

Volume 2, Number 3—July 1996

Dispatch

HIV-1 Group O Virus Identified for the First Time in the United States

M. A. Rayfield*, P. Sullivan†, C. I. Bandea*, L. Britvan‡, R. A. Otten*, C. P. Pau*, D. Pieniazek*, S. Subbarao*, P. Simon†, C. A. Schable*, A. C. Wright*, J. Ward†, and G. Schochetman*
Author affiliations: Author Affiliations: ; *National Center for Infectious Diseases; †National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ‡Kaiser Permanente Medical Group, Los Angeles, California, USA

Main Article

Table 2

Typical peptide reactivity patterns.

Subtype V3-A V3-B V3-C V3-D V3-E V3-F V3-O GP41-M GP41-O
A 2.742 1.144 1.628 0.065 0.083 0.724 0.055 2.683 2.627
B 0.071 1.271 0.051 0.030 0.033 0.038 0.028 2.570 2.414
C 2.320 0.084 2.515 0.079 1.647 1.637 0.061 2.746 2.858
D 0.210 0.079 0.056 1.203 0.048 0.051 0.040 1.380 0.279
E 0.055 0.043 0.385 0.042 1.291 0.038 0.025 0.619 0.340
F 0.062 0.857 0.041 0.037 0.039 0.033 0.037 2.615 2.670
O 0.089 0.088 0.089 0.188 0.088 0.081 1.704 0.070 2.457

GP41-M and GP41-O refer to peptides derived from the consensus gp41 sequences for Group M and Group O variants.

Main Article

1Primers: gag/outer/forward - AGTACATGTTAAAACATGTAGTATGGGC; gag/outer/ reversed - CCTACTCCCTGACAGGCCGT CAGCATTTCTTC; gag/inner/forward - AGTACATGTTAAAACATGTAGTATGGGC; gag/inner/reverse - CCTTAAGCTTTTGT AGAATCTATCTACATA; protease/outer/forward - TTTGCCTCCCTCAAATC; protease/outer/reverse - TTACTGGCACTG GGGCTATGG; protease/inner/ forward - CCTCAAATCCCTCTTTG; protease/inner/reverse - TATAGGGAAGTTTAGTGTACA; env/outer/forward - CACAGAATTTAATGGAACAGGC; env/outer/reverse - TGTGTT ACAATAAAAGAATTCTCC; env/inner/forward - GTTACTTGTACACATGGCAT; and env/inner/reverse - AGAATTCTCCATGACAGTTAAA.

Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external